- Home
- RYI vs FDMT Comparison
RYI vs FDMT Comparison
Compare RYI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYI
- FDMT
- Stock Information
- Founded
- RYI 1842
- FDMT 2013
- Country
- RYI United States
- FDMT United States
- Employees
- RYI N/A
- FDMT N/A
- Industry
- RYI Metal Fabrications
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- RYI Industrials
- FDMT Health Care
- Exchange
- RYI Nasdaq
- FDMT Nasdaq
- Market Cap
- RYI 607.6M
- FDMT 268.6M
- IPO Year
- RYI N/A
- FDMT 2020
- Fundamental
- Price
- RYI $20.01
- FDMT $4.88
- Analyst Decision
- RYI Hold
- FDMT Buy
- Analyst Count
- RYI 1
- FDMT 11
- Target Price
- RYI $28.00
- FDMT $41.70
- AVG Volume (30 Days)
- RYI 280.0K
- FDMT 1.1M
- Earning Date
- RYI 02-19-2025
- FDMT 02-27-2025
- Dividend Yield
- RYI 3.81%
- FDMT N/A
- EPS Growth
- RYI N/A
- FDMT N/A
- EPS
- RYI 0.64
- FDMT N/A
- Revenue
- RYI $4,703,700,000.00
- FDMT $17,000.00
- Revenue This Year
- RYI N/A
- FDMT N/A
- Revenue Next Year
- RYI $1.76
- FDMT $159.49
- P/E Ratio
- RYI $30.98
- FDMT N/A
- Revenue Growth
- RYI N/A
- FDMT N/A
- 52 Week Low
- RYI $17.18
- FDMT $4.68
- 52 Week High
- RYI $36.15
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- RYI 49.22
- FDMT 32.10
- Support Level
- RYI $17.18
- FDMT $4.68
- Resistance Level
- RYI $18.73
- FDMT $6.67
- Average True Range (ATR)
- RYI 0.77
- FDMT 0.43
- MACD
- RYI 0.24
- FDMT -0.02
- Stochastic Oscillator
- RYI 99.47
- FDMT 10.30
About RYI Ryerson Holding Corporation
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority is from the United States.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.